Company Active LTD

Company profile

Applied Nanodetectors Limited

Learn what we do | Applied Nanodetectors Ltd

Transforming respiratory disease healthcare with our point of care breath platform. Our solution includes a device and software to deliver self-care programs.

CRN
05220538
Founded
2004
Age
21

Overview

Legal name
APPLIED NANODETECTORS LIMITED
Region
London
Registered address
36 WATERLOW COURT
HEATH CLOSE
LONDON
NW11 7DT
Insolvency history
No

Latest accounts

Financial period: 1 Oct 2023 to 30 Sep 2024

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
3

Company events

Reference milestones and recent Companies House filing stream events.

6 events
16 Sep
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Jun
2026

Accounts due

Accounts Due

Next accounts due date

02 Sep
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

03 Oct
2024

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzQzODI5NDkyMGFkaXF6a2N4

Published 03 Oct 2024 11:49

30 Sep
2024

Accounts filed

Accounts

Last accounts made up date

02 Sep
2004

Incorporated

Inception

Company registered at Companies House

Public funding

16 awards
First funded
2013
Funded years
2013, 2014, 2015, 2016, 2017, 2019, 2020, 2021, 2023, 2024
Age at first award
8 years

Projects

2024 Collaborative R&D Lead participant

Indoor air quality measurements of formaldehyde using low cost sensors

1 Jan 2024 to 31 Mar 2024

Awarded
£21,961
Total cost £21,961

Formaldehyde is a significant health risk, and International Agency for Research on Cancer (IARC) classifies formaldehyde as a human carcinogen. There are stringent formaldehyde exposure guidelines that exist for indoor air (80 ppb WHO) that can be even lower at the national level (e.g., France 8 ppb by 2023). People are exposed to formaldehyde from a var...

2023 Collaborative R&D Lead participant

Trustworthy AI software platform for technical and non-technical users

1 May 2023 to 31 Jul 2023

Awarded
£49,640
Total cost £49,640

The project consists of an integrated software platform that provides connecting information for technical and non-technical stakeholders, facilitating the implementation and monitoring of Trustworthy AI within organisations. This platform comprises four main unique features: 1. Technical information platform 2. Non-technical information platform 3. Check...

2021 Small Business Research Initiative Lead participant

Smarter Home Indoor Air Quality Monitoring System

1 Jul 2021 to 30 Jun 2022

Awarded
£297,594
Total cost £297,594

Indoor air quality (IAQ) is one of the leading environmental risks, which affects people's, comfort, health, and well-being. People spend around 90% of their time indoors, and daily exposure to indoor air pollutants may occasionally be more than 10 times higher than outdoor pollutant (EPA). It is estimated, for instance, that up to 20% of the population s...

2020 Small Business Research Initiative Lead participant

Smarter Home Indoor Air Quality Monitoring System

1 Oct 2020 to 31 Dec 2020

Awarded
£19,853
Total cost £19,853
2020 Feasibility Studies Lead participant

Lung function device to aid COVID-19 management in care homes

1 Jun 2020 to 31 Mar 2021

Awarded
£74,523
Total cost £74,523

The COVID-19 pandemic raises particular challenges for the 400,000 UK care home residents, their families and the key staff that look after them. Recent guidance from the British Geriatric Society has been developed to help care home staff and NHS staff who work with them to support residents through the pandemic. This guidance recommends that where possi...

2020 Feasibility Studies Lead participant

POC-Breath test for home management of respiratory disease

1 Jun 2020 to 31 Mar 2021

Awarded
£36,265
Total cost £36,265

no public description

2019 Feasibility Studies Lead participant

POC-Breath test for home management of respiratory disease

1 Apr 2019 to 30 Jun 2021

Awarded
£184,048
Total cost £262,926

Chronic Obstructive Pulmonary Disease (COPD) and asthma are leading causes of morbidity and mortality worldwide and have a significant economic and social burden. Significant challenges include delays in an accurate diagnosis, maintaining good disease control and the identification of exacerbations, which consume a disproportionate share of expenditure du...

2019 Collaborative R&D Lead participant

FeNO asthma diagnostic

1 Feb 2019 to 31 Jan 2020

Awarded
£69,619
Total cost £99,456

"Applied Nanodetectors (AND) propose to investigate the feasibility of a low cost fractional exhaled nitric oxide (FeNO) breath test for the diagnosis of asthma for use in primary care settings. The rapid and accurate diagnosis of asthma and identification of patients would be essential to ensure that adequate treatment, including hospitalisation when nec...

2019 Feasibility Studies Lead participant

POC-ASTHMA: Point of care exhaled breath test for asthma diagnosis

1 Jan 2019 to 31 Dec 2019

Awarded
£117,839
Total cost £168,341

"We propose to investigate the feasibility of a point of care (POC) exhaled breath test for the diagnosis of asthma for use in primary care setting. The rapid and accurate diagnosis of asthma and identification of patients would be essential to ensure that adequate treatment, including hospitalisation when necessary, is implemented as early as possible. T...

2017 Collaborative R&D Lead participant

MP-SENS: Manufacturing processes for hybrid sensor module

1 Nov 2017 to 31 Mar 2019

Awarded
£226,915
Total cost £324,164

Applied Nanodetectors has developed a sensor array platform that can be used for a number of market opportunities. Each sensor array is composed of different sensor elements produced using specific nanomaterials, which can be used for chemical and biosensors. This sensor array can be designed in the same physical space and allows forward integration into ...

2016 Collaborative R&D

Newton Fund - Development and validation of low-cost field sensor and filtration technologies for real-time detection and removal of drinking water contaminants (As/F-)

1 Oct 2016 to 29 Feb 2020

Awarded
£114,847
Total cost £164,067

Millennium Develop Goal 7c - to reduce by half the 4 billion people without sustainable access to safe drinking water - has encouraged rapid growth in water quality testing. Despite this, exposure to high levels of arsenic & fluoride through contaminated drinking water remains a global health problem, affecting an estimated 300m people worldwide & over 6m...

2015 Feasibility Studies Lead participant

An investigation into the feasibility of fabrication of inkjet SERS sensors to detect bacteria in sputum samples for the early detection of excerbations in chronic obstructive pulmonary disease (COPD)

1 Jun 2015 to 30 Sep 2015

Awarded
£23,100
Total cost £33,000

Chronic obstructive pulmonary disease (COPD) is a prevalent lung disease (3 Million in UK) that accounts for a major burden in the UK in terms of morbidity (25,000 deaths a year) and health care costs (£4bn). COPD is punctuated by exacerbations which are episodes of increased respiratory symptoms associated with systemic and airway inflammation. Most exac...

Product types

Collaborative R&D Feasibility Studies Small Business Research Initiative